Ignite Creation Date:
2024-05-05 @ 6:31 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00499694
Status:
COMPLETED
Last Update Posted:
2018-06-12
First Post:
2007-07-10
Brief Title:
Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Barbara Ann Karmanos Cancer Institute
Organization Data
Organization:
Barbara Ann Karmanos Cancer Institute
Class:
OTHER
Study ID:
CDR0000518085
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Barbara Ann Karmanos Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
Ulka Vaishampayan
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Barbara Ann Karmanos Cancer Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |